UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063079
Receipt number R000072212
Scientific Title Randomized, double-blind, crossover trial on the effects of dextrin intake on the improvement of exercise performance
Date of disclosure of the study information 2026/09/28
Last modified on 2026/09/28 17:13:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized, double-blind, crossover trial on the effects of dextrin intake on the improvement of exercise performance

Acronym

Randomized, double-blind, crossover trial on the effects of dextrin intake on the improvement of exercise performance

Scientific Title

Randomized, double-blind, crossover trial on the effects of dextrin intake on the improvement of exercise performance

Scientific Title:Acronym

Randomized, double-blind, crossover trial on the effects of dextrin intake on the improvement of exercise performance

Region

Japan


Condition

Condition

Healthy male Ekiden team member

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of ingesting highly branched cyclic dextrin which is digested and absorbed relatively slowly on performance in a long-distance running time trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Time trial score

Key secondary outcomes

Heart rate, gastrointestinal strain scores before and after the experiment, and fatigue scores after the experiment.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food

Interventions/Control_1

Duration: 1 day
Test product: Beverage containing highly branched cyclic dextrin

Interventions/Control_2

Duration: 1 day
Test product: glucose-containing drink

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

25 years-old >

Gender

Male

Key inclusion criteria

Healthy male Ekiden team members aged 18 to under 25

Key exclusion criteria

1 Individuals with diabetes or abnormal glucose metabolism
2 Individuals using medications that affect blood glucose levels

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Sato

Organization

Shibaura Institute of Technology

Division name

College of Systems Engineering and Science

Zip code

337-8570

Address

307 Fukasaku, Minuma-ku, Saitama-shi, Saitama

TEL

048-720-6016

Email

hiroki@shibaura-it.ac.jp


Public contact

Name of contact person

1st name Yumi
Middle name
Last name Hosogi

Organization

Glico Nutrition Co., Ltd.

Division name

R&D Center

Zip code

555-8502

Address

4-6-5, Utajima, Nishiyodogawa-Ku, Osaka, Japan

TEL

050-1744-4293

Homepage URL


Email

yumi.hosogi@glico.com


Sponsor or person

Institute

Glico Nutrition Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Glico Nutrition Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Shibaura Institute of Technology, College of Systems Engineering and Science, Department of Life Sciences

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shibaura Institute of Technology Research Ethics Committee for Biotechnology

Address

3-7-5 Toyosu, Koto-ku, Tokyo

Tel

03-5859-9821

Email

kato.minami@ow.shibaura-it.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

芝浦工業大学(埼玉県)


Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

14

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2026 Year 08 Month 25 Day

Date of IRB

2026 Year 08 Month 25 Day

Anticipated trial start date

2026 Year 09 Month 05 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 09 Month 28 Day

Last modified on

2026 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072212